We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWAND.L Regulatory News (WAND)

  • There is currently no data for WAND

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board Changes

26 Jul 2023 07:00

RNS Number : 1756H
WANdisco Plc
26 July 2023
 

26 July 2023

WANdisco plc 

 

("WANdisco" or the "Company") 

 

Board Changes 

 

WANdisco (LSE: WAND), the data activation platform, announces a number of changes to the Board effective 25 July 2023 as follows:

 

· Stephen Kelly will join the Board as Chief Executive Officer having served as Interim Chief Executive Officer since 10 May 2023.

· Ijoma Maluza will join the Board as Chief Financial Officer having served as Interim Chief Financial Officer since 11 April 2023.

· Xenia Walters will join the Board as a Non-Executive Director and Chair of the Audit and Risk Committee.

· Chris Baker will join the Board as a Non-Executive Director and Chair of the Remuneration Committee.

· Karl Monaghan, Non-Executive Director and current Chair of the Audit and Risk Committee and the Remuneration Committee will step down from the Board ahead of the next Annual General Meeting in August.

· Yeturu Aahlad, Chief Scientist, will step down from the Board and will remain a member of the Executive Team.

 

Peter Lees will remain as Senior Independent Director and continue to be Chair of the Nomination Committee. Ken Lever remains as Non-Executive Interim Chairman. As previously announced, now that the refinancing has been completed and the share suspension has been lifted, a process will commence to identify a permanent Non-Executive Chair of the Board. Ken Lever will engage in that process.

 

Xenia Walters is a senior finance leader with an excellent track record of delivering operational and profit improvements within fast paced environments - both on the public markets and within private equity backed global operations. Xenia began her career with PriceWaterhouseCoopers (1991 to 1997) and during her career worked in various finance roles at Allied Colloids plc, Ciba Speciality Chemicals and Huntsman Chemicals. Xenia was with Regus plc from 2003 to 2011, initially as Group Financial Controller then as UK CFO. She was Group Finance Director of INTO University Partnerships and then Interim CFO of Oxford International Education Group until 2015, ultimately leading to her assuming the role of Group Chief Financial Officer of SDL plc and then Group CFO of Snowfox Group.

 

Chris Baker is an experienced leader in the international technology industry and currently a partner of CBCS Associates, a software advisory business. From 1983 to 1997 Chris was with Digital Equipment Company, rising to serve as UK Sales Director for Outsourcing. During the period 1997 to 2014, Chris held several senior roles within Oracle, rising to Senior Vice President and Worldwide Head of ISV/OEM/Java Sales. Chris was then Executive Director of Xchanging plc from 2014 to 2016, leading the Xuber Insurance Software business, and from 2016 to 2021 Chris was CEO of Capita Software.

 

Ken Lever, Interim Non-Executive Chairman, commented:

"Following the successful refinancing of WANdisco and the lifting of the share suspension, we are now able to formally shape the Board to support growth and value creation for shareholders. I am delighted that Chris and Xenia have agreed to join us at this very important juncture in the re-establishment of the Company as a leading business in the data-integration software market. I am very appreciative of the significant commitment shown by Karl and Aahlad to the Board's activities, especially during the very challenging times for the Company."

 

For further information, please contact:

 

FTI Consulting

 

+44 (0)20 3727 1137

Rob Mindell / Kwaku Aning / Tom Blundell / Matt Dixon

 

 

 

Stifel (Nomad and Joint Broker)

 

 

+44 (0)20 7710 7600

Fred Walsh / Richard Short / Tom Marsh

 

 

Liberum (Joint Broker)

 

Max Jones / Ben Cryer / Miquela Bezuidenhoudt

 

+44 (0)20 3100 2000

 

 

About WANdisco

WANdisco is the data activation platform for accelerating digital transformation at scale. WANdisco makes infinite data actionable across clouds and enterprises in real time. WANdisco customers unleash the business value of the cloud with zero downtime, data loss, or disruption to fuel AI and machine learning, create new services, and transform businesses. For more information about WANdisco, visit www.wandisco.com

 

Regulatory disclosures

Stephen Paul Caulfield Kelly

The following information is provided pursuant to Rule 17 and with Schedule Two paragraph (g) of the AIM Rules for Companies in relation to Stephen Kelly (age 61):

 

Current Directorships

Previous Directorships

Optimise (The Algorithm People) Limited

Locums Nest Ltd

Tech Nation Group Limited

Tech City Group Limited

Kimble Applications Limited

The Sage Group Plc

 

As of the date of this announcement, Stephen Kelly holds a beneficial interest in 934,080 ordinary shares of the Company. Save as disclosed above there are no additional disclosures to be made in accordance with Rule 17 or Schedule Two paragraph (g) of the AIM Rules for Companies in respect of Stephen Kelly.

 

Ijoma Patrick Tilowakuti Maluza

The following information is provided pursuant to Rule 17 and with Schedule Two paragraph (g) of the AIM Rules for Companies in relation to Ijoma Maluza (age 44):

 

Current Directorships

Previous Directorships

-

Blue Prism Limited

Blue Prism Cloud Limited

Blue Prism Group Limited

 

As of the date of this announcement, Ijoma Maluza holds a beneficial interest in 3,000 ordinary shares of the Company. Save as disclosed above there are no additional disclosures to be made in accordance with Rule 17 or Schedule Two paragraph (g) of the AIM Rules for Companies in respect of Ijoma Maluza.

 

 

 

Xenia Walters (maiden name Constantinou)

The following information is provided pursuant to Rule 17 and with Schedule Two paragraph (g) of the AIM Rules for Companies in relation to Xenia Walters (age 53):

 

Current Directorships

Previous Directorships

-

Snowfox Group Plc

YO! Sushi Ltd

Asian Counters UK Ltd

Sushi UK Holdco Ltd

YO! Sushi UK Ltd

Snowfox BidCo Ltd

Snowfox MidCo Ltd

Snowfox MidCo 2 Ltd

Taiko Foods Ltd

YO! Sushi Americas Ltd

SDL Plc

SDL Ltd

 

As of the date of this announcement, Xenia Walters does not hold any beneficial interest in the ordinary shares of the Company. Save as disclosed above there are no additional disclosures to be made in accordance with Rule 17 or Schedule Two paragraph (g) of the AIM Rules for Companies in respect of Xenia Walters.

 

Christopher Francis Henry Baker

The following information is provided pursuant to Rule 17 and with Schedule Two paragraph (g) of the AIM Rules for Companies in relation to Chris Baker (age 67):

 

Current Directorships

Previous Directorships

Benric Ltd

Curo Charlotte House LLP

 

Capita Business Services Ltd

Clinical Solutions Holdings Ltd

Clinical Solutions International Ltd

Clinical Solutions Finance Ltd

Capita Justice & Secure Services Holdings Ltd

Metacharge Ltd

Capita Secure Information Solutions Ltd

Pay360 Ltd

Clinical Solutions IP Ltd

Marrakech (UK) Ltd

AMT-Sybex Ltd

Clinical Solutions Acquisition Ltd

Retain International Ltd

Brentside Communications Ltd

Retain International (Holdings) Ltd

Education Software Solutions

The G2G3 Group Ltd

Pageone Communications Ltd

Eclipse (Hardware) Ltd

Tempus Finance Ltd

Micro Librarian Systems Ltd

Complete Imaging Ltd

Capita Mortgage Software Solutions Ltd

Barrachd Ltd

Westpoint Ltd

Smartpoint Ltd

Hallco 1626 Ltd

ITR International Translation Resources Ltd

G2G3 Digital Ltd

Data Equipment Ltd

Barrachd Intelligence Solutions Ltd

Security Watchdog Ltd

Amity Communications Ltd

Data Mail Systems Ltd

Aspire Business Solutions

Sigma Seven Ltd

AMT-Sybex Holdings Ltd

Capita Secure Mobile Solutions Ltd

Complete Imaging Trustee Company Ltd

G2G3 Propulsion Ltd

 

As of the date of this announcement, Chris Baker does not hold any beneficial interest in the ordinary shares of the Company. Save as disclosed above there are no additional disclosures to be made in accordance with Rule 17 or Schedule Two paragraph (g) of the AIM Rules for Companies in respect of Chris Baker.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAKELFLXDLZBBZ
Date   Source Headline
4th Oct 20237:00 amRNSWANdisco plc rebrands as Cirata plc
22nd Sep 20236:24 pmRNSHolding(s) in Company
11th Sep 20237:00 amRNSInterim results
7th Sep 20233:30 pmRNSNotice of Results
30th Aug 20236:04 pmRNSResult of Annual General Meeting
18th Aug 20236:05 pmRNSBlock Admission Notification
16th Aug 20238:07 amRNSGM Signs Multi-Project Contract with WANdisco
31st Jul 20237:00 amRNSHolding(s) in Company
28th Jul 20233:25 pmRNSHolding(s) in Company
26th Jul 20237:00 amRNSBoard Changes
25th Jul 20237:30 amRNSRestoration - WANdisco plc
25th Jul 20237:00 amRNSConfirmation of Exchange Rate
24th Jul 202310:45 amRNSResult of GM
17th Jul 20235:00 pmRNSPosting of Annual Report and Accounts
12th Jul 20231:45 pmRNSPublication of Annual Report and Accounts
11th Jul 20237:00 amRNSContract Win
10th Jul 20237:00 amRNSContract Renewal
7th Jul 20237:00 amRNSConfirmation of Fundraise
5th Jul 20236:29 pmRNSPublication of Notice of General Meeting
5th Jul 202311:30 amRNSUpdate to Fundraise Timetable
4th Jul 20237:00 amRNSResult of Fundraising
3rd Jul 202312:00 pmRNSLaunch of Fundraise
29th Jun 20237:00 amRNSPreliminary Unaudited Results FY22
28th Jun 202311:51 amRNSUpdate on Timing of Results and Equity Issue
26th Jun 20233:30 pmRNSTurnaround Plan Momentum
26th Jun 20237:00 amRNSWANdisco Signs New Agreement with Accenture
15th Jun 20239:46 amRNSFCA investigation timeline update
9th Jun 20237:00 amRNSSuccessful Shareholder General Meeting Next Steps
6th Jun 20233:49 pmRNSResult of General Meeting
19th May 20236:22 pmRNSPublication of Circular and Notice of GM
19th May 20236:04 pmRNSBoard Change
15th May 20237:00 amRNSExploring Funding Options
9th May 20235:30 pmRNSWANdisco
9th May 20237:00 amRNSAppointment of Interim Chief Executive
4th May 20237:00 amRNSOrganisation Update
28th Apr 20237:00 amRNSIndependent Investigation Update
20th Apr 20237:00 amRNSFCA Investigation
5th Apr 20237:00 amRNSExecutive Chair Appointment Confirmation
4th Apr 20237:00 amRNSContract Renewals
3rd Apr 20237:00 amRNSBoard Change and Investigation Update
22nd Mar 20237:00 amRNSAppointment of Interim Chair
10th Mar 20239:31 amRNSIndependent Investigation Appointment
9th Mar 20237:30 amRNSSuspension - WANdisco plc
9th Mar 20237:00 amRNSTrading Revision
7th Mar 20237:00 amRNSAppointment of Joint Broker
6th Mar 20237:00 amRNSResponse to press speculation
1st Mar 20238:16 amRNSTotal Voting Rights
1st Feb 20234:05 pmRNSTotal Voting Rights
24th Jan 20237:00 amRNS$9m industrial and consumer goods contract win
11th Jan 20237:00 amRNSFY22 Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.